Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

3,408 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
From Genetics to Psychosocial Functioning: Unraveling the Mediating Roles of Cognitive Reserve, Cognition, and Negative Symptoms in First-Episode Psychosis.
Forte MF, Clougher D, Segura ÀG, Mezquida G, Sánchez-Torres AM, Vieta E, Garriga M, Lobo A, González-Pinto AM, Diaz-Caneja CM, Roldan A, Martínez-Arán A, de la Serna E, Mané A, Mas S, Torrent C, Allot K, Bernardo M, Amoretti S; PEPs Group. Forte MF, et al. Acta Psychiatr Scand. 2024 Dec 25. doi: 10.1111/acps.13779. Online ahead of print. Acta Psychiatr Scand. 2024. PMID: 39722475
Interrelationships between polygenic risk scores, cognition, symptoms, and functioning in first-episode psychosis: A network analysis approach.
Gil-Berrozpe GJ, Segura AG, Sánchez-Torres AM, Amoretti S, Giné-Servén E, Vieta E, Mezquida G, Lobo A, Gonzalez-Pinto A, Andreu-Bernabeu A, Roldán A, Forte MF, Castro J, Bergé D, Rodríguez N, Ballesteros A, Mas S, Cuesta MJ, Bernardo M; PEPs group. Gil-Berrozpe GJ, et al. Among authors: castro j. Eur Neuropsychopharmacol. 2024 Dec 24;92:52-61. doi: 10.1016/j.euroneuro.2024.12.002. Online ahead of print. Eur Neuropsychopharmacol. 2024. PMID: 39721378
Long-term effectiveness and tolerability of dolutegravir/lamivudine in treatment-naive people with HIV: an analysis of a multicentre cohort at 96 weeks.
Suárez-García I, Alejos B, Moreno C, Martín Torres J, Masiá M, García-Fraile LJ, Riera M, Dalmau D, Rodríguez-Rosado R, Muga R, Moreno S, Jarrín I; CoRIS cohort. Suárez-García I, et al. J Antimicrob Chemother. 2024 Dec 23:dkae456. doi: 10.1093/jac/dkae456. Online ahead of print. J Antimicrob Chemother. 2024. PMID: 39710424
Respiratory Syncytial Virus Disease Burden and Nirsevimab Effectiveness in Young Children From 2023-2024.
Moline HL, Toepfer AP, Tannis A, Weinberg GA, Staat MA, Halasa NB, Boom JA, Klein EJ, Williams JV, Schuster JE, Goldstein L, McKeever ER, Kalman C, Paden C, Atherton L, Aggarwal M, Roychoudhury P, Piedra PA, Sahni LC, Stewart LS, Selvarangan R, Michaels MG, Schlaudecker EP, Szilagyi PG, Englund JA, Clopper BR, Thornburg NJ, Derado G, McMorrow ML, Dawood FS; New Vaccine Surveillance Network Collaborators. Moline HL, et al. JAMA Pediatr. 2024 Dec 9:e245572. doi: 10.1001/jamapediatrics.2024.5572. Online ahead of print. JAMA Pediatr. 2024. PMID: 39652359
3,408 results